ArticleInfection prevention in practice2026
Hepatitis B virus testing, vaccination, and hepatitis B surface antigen prevalence among adult inpatients at an urban polyclinic in Accra, Ghana: a cross-sectional study.
Article in Infection prevention in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hepatitis B virus (HBV) infection is endemic in Ghana, mostly due to vertical transmission and limited vaccine coverage. We estimated hepatitis B surface antigen (HBsAg) prevalence and assessed HBV infection, testing, vaccination, and associated risk factors among adult inpatients receiving care at an urban polyclinic. Methods: A hospital-based cross-sectional study was conducted among 313 adult inpatients at Kaneshie Polyclinic (Accra) from September 2020 to September 2021. We administered structured questionnaires, collected venous blood via standard venipuncture, and detected HBsAg using ACON One Step rapid immunochromatographic test, with 99.9% sensitivity and 99.7% specificity. All reactive tests were repeated for confirmation. Pearson's χ Results: Participants' average age was 43.2 (±12.2 SD) years, and the majority were married (71.9%) and male (54.6%). HBsAg prevalence was 14.4% (95% confidence interval [CI]: 10.7-18.8). Prior HBV testing occurred in 32.6%, and full vaccination (≥3 doses) in 11.8%. None of the fully vaccinated participants were HBsAg-positive. Family history was positively associated with infection (adjusted odds ratio [AOR]: 2.54; 95% CI: 1.05-6.16), while low monthly income was associated with reduced odds of hepatitis B testing (AOR: 0.18, 95% CI: 0.05-0.62) and vaccination (AOR: 0.55, 95% CI: 0.17-1.82). Vaccination was protective in those who received it. Conclusion: This study found a high prevalence of HBsAg positivity, low testing, and inadequate vaccine coverage among inpatients in an urban polyclinic. To reduce transmission risks, population-specific interventions that raise public knowledge of HBV transmission and prevention are required. Findings also support routine HBV screening and subsidized vaccination for adult inpatients, with targeted outreach to low-income groups and household contacts of known cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.